United Therapeutics Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
43.56 M |
Public Float |
38.02 M |
United Therapeutics Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.44 |
Market Cap |
$3.51 B |
Shares Outstanding |
43.81 M |
Public Float |
42.36 M |
Address |
1040 Spring Street Silver Spring Maryland 20910 United States |
Employees | - |
Website | http://www.unither.com |
Updated | 07/08/2019 |
United Therapeutics Corp. biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. |